Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome

Emerging Infectious Diseases

Volumn 14, Issue 3, 2008, Pages 406-411

  Pettersson, Lisa ^a,d   Klingström, Jonas ^a,b,c   Hardestam, Jonas ^b,c   Lundkvist, Åke ^b,c   Ahlm, Clas ^a   Evander, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HANTAVIRUS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PUUMALA VIRUS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SALIVA ANALYSIS; SWEDEN; SYMPTOMATOLOGY; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION;

EID: 41349108498     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1403.071242     Document Type: Article

References (36)

1. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 1997;3:95-104.
2. Settergren B, Juto P, Trollfors B, Wadell G, Norrby SR. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis. 1989;11:921-7.
3. Douron E, Moriniere B, Matheron S, Girard PM, Gonzales JP, Hirsch F, et al. HFRS after a wild rodent bite in the Haute-Savoie - and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet. 1984;1:676-7.
4. St Jeor SC. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J. 2004;23:974-5.
5. Yanagihara R, Amyx HL, Gajdusek DC. Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus). J Virol. 1985;55:34-8.
6. Padula P, Figueroa R, Navarrete M, Pizarro E, Cadiz R, Bellomo C, et al. Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J Virol. 2004;78:11972-9.
7. Botten J, Mirowsky K, Ye C, Gottlieb K, Saavedra M, Ponce L, et al. Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J Virol. 2002;76:7587-94.
8. Wells RM, Sosa Estani S, Yadon ZE, Enria E, Padula P, Pini N, et al. An unusual hantavirus outbreak in southern Argentina: person-toperson transmission? Emerg Infect Dis. 1997;3:171-4.
9. Toro J, Vega JD, Khan AS, Mills JN, Padula P, Terry W, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis. 1998;4:687-94.
10. Padula PJ, Edelstein A, Miguel SD, López NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology. 1998;241:323-30.
11. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005;11:1848-53.
12. Lázaro ME, Cantoni GE, Calanni LM, Resa AJ, Herrero ER, Iacono MA, et al. Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis. 2007;13:104-10.
13. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, et al. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J Infect Dis. 2007;195:1563-71.
14. Faulkner GC, Krajewski AS, Crawford DH. The ins and outs of EBV infection. Trends Microbiol. 2000;8:185-9.
15. Pica F, Volpi A. Transmission of human herpes virus 8: an update. Curr Opin Infect Dis. 2007;20:152-6.
16. Yoshikawa T, Ihira M, Taguchi H, Yoshida S, Asado Y. Analysis of shedding of 3 beta-herpesviruses in saliva from patients with connective tissue diseases. J Infect Dis. 2005;192:1530-6.
17. Bergey EJ, Gu M, Collins AR, Bradway SD, Levine MJ. Modulation of herpes simplex virus type 1 replication by human salivary secretions. Oral Microbiol Immunol. 1993;8:89-93.
18. Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C, Olsson GE, et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol. 2007;45:2491-7.
19. Johansson P, Olsson M, Lindgren L, Ahlm C, Elgh F, Holmström A, et al. Complete gene sequence of a human Puumala hantavirus isolate, Puumala Umeå/hu:sequence comparison and characterisation of encoded gene products. Virus Res. 2004;105:147-55.
20. Johansson P. Implications of local Puumala hantavirus genetics and epidemiology for diagnostics and vaccine development [Ph.D thesis]. Umea (Sweden): Umeå University; 2005.
21. Navarrete M, Pizarro E, Méndez C, Salazar P, Padula P, Zarov L, et al. Hantavirus ANDV distribution in human lungs and salivary glands. In: Abstracts of the VII international conference on HFRS, HCPS and hantaviruses; 2007 Jun 13-15; Buenos Aires, Argentina; 2007; Abstract 103.
22. Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis. 2004;10:1213-9.
23. von Linstow ML, Eugen-Olsen J, Koch A, Winther TN, Westh H, Hogh B. Excretion patterns of human metapneumovirus and respiratory syncytial virus among young children. Eur J Med Res. 2006;11:329-35.
24. Ahlm C, Settergren B, Gothefors L, Juto P. Nephropathia epidemica (hemorrhagic fever with renal syndrome) in children: clinical characteristics. Pediatr Infect Dis J. 1994;13:45-9.
25. Linderholm M, Billstrom A, Settergren B, Tarnvik A. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection. 1992;20:263-6.
26. Linderholm M, Bjermer L, Juto P, Roos G, Sandstrom T, Settergren B, et al. Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis. 1993;25:639-46.
27. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol. 1996;46:369-78.
28. Linderholm M, Sandstrom T, Rinnstrom O, Groth S, Blomberg A, Tarnvik A. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis. 1997;25:1084-9.
29. Lundkvist Å, Cheng Y, Brus Sjölander K, Niklasson B, Vaheri A, Plyusnin A. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment. J Virol. 1997;71:9515-23.
30. Juto P, Elgh F, Ahlm C, Alexeyev OA, Edlund K, Lundkvist Å, et al. The first human isolate of Puumala virus in Scandinavia as cultured from phytohemagglutinin stimulated leucocytes. J Med Virol. 1997;53:150-6.
31. Padula PJ, Rossi CM, Della Valle MO, Martínez PV, Colavecchia SB, Edelstein A, et al. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol. 2000;49:149-55.
32. Klingström J, Plyusnin A, Vaheri A, Lundkvist Å. Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in Cynomolgus macaques. J Virol. 2002;76:444-9.
33. Mandel ID. The functions of saliva. J Dent Res. 1987;66:623-7.
34. Fox PC, Wolff A, Yeh C, Atkinson J, Baum BJ. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc. 1988;116:635-7.
35. Hartshorn KL, Ligtenberg A, White MR, Van Eijk M, Hartshorn M, Pemberton L, et al. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J. 2006;393:545-53.
36. Pettersson L, Boman J, Juto P, Evander M, Ahlm C. Outbreak of Puumala virus infection, Sweden. Emerg Inf Dis. In press.